Want to see JP:7090 full AI Analyst Report?

LIGUA, Inc. (7090) Price & Analysis

0 Followers

7090 Stock Chart & Stats

¥920.00

¥150.00(16.30%)

At close: Jan 08 4:00 PM EST

¥920.00

¥150.00(16.30%)

Day’s Range― - ―

52-Week Range¥703.00 - ¥1,705.00

Previous CloseN/A

Volume4.80K

Average Volume (3M)15.67K

Market Cap

¥1.30B

Enterprise Value¥1.94B

Total Cash (Recent Filing)¥1.19B

Total Debt (Recent Filing)¥1.62B

Price to Earnings (P/E)―

Beta0.54

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-159.25

Shares Outstanding1,611,800

10 Day Avg. Volume7,040

30 Day Avg. Volume15,666

Financial Highlights & Ratios

PEG Ratio0.29

Price to Book (P/B)8.38

Price to Sales (P/S)0.61

P/FCF Ratio5.85

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Improving Cash GenerationReturn to positive and rising operating cash flow and free cash flow demonstrates the company's ability to generate internal liquidity despite earnings volatility. Durable cash generation supports working capital, funds de-risking or reinvestment, and reduces near-term refinancing pressure over the next several quarters.

Debt Reduction TrendMeasured reduction of total debt over multiple years is a structural de-risking step that improves financial flexibility. Sustained debt paydown, if continued, lowers interest burden and default risk, making the company less sensitive to operating setbacks and more able to invest in stability or growth.

Meaningful Gross Profit And Industry ExposureRetained gross profit dollars plus exposure to the medical instruments industry provide a durable revenue base tied to healthcare demand. Even with operating issues, solid gross margins indicate product-level economics that can support recovery if SG&A or operating leverage is restored.

Bears Say

Revenue ContractionSustained top-line declines over consecutive years reduce operating scale and impair fixed-cost absorption, pressuring margins and cashflows. If revenue shrinkage persists, it undermines long-term profitability prospects and makes recovery dependent on successful product or market repositioning.

Return To Material LossesReversion from profitability to sizable multi-year losses signals persistent cost, pricing, or demand issues that impair sustainable earnings power. Continued negative EBIT erodes equity and limits reinvestment capacity, making durable recovery contingent on structural cost remediation or revenue stabilization.

Equity Erosion And LeverageMaterial erosion of equity alongside still-elevated debt leaves the capital structure fragile and increases sensitivity to future losses or cash shortfalls. Thin equity reduces financial flexibility, raises refinancing and covenant risk, and limits the company's ability to absorb adverse shocks sustainably.

7090 FAQ

What was LIGUA, Inc.’s price range in the past 12 months?

LIGUA, Inc. lowest stock price was ¥703.00 and its highest was ¥1705.00 in the past 12 months.

What is LIGUA, Inc.’s market cap?

LIGUA, Inc.’s market cap is ¥1.30B.

When is LIGUA, Inc.’s upcoming earnings report date?

LIGUA, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 5 days.

How were LIGUA, Inc.’s earnings last quarter?

LIGUA, Inc. released its earnings results on May 14, 2026. The company reported -¥22.61 earnings per share for the quarter, missing the consensus estimate of N/A by -¥22.61.

Is LIGUA, Inc. overvalued?

According to Wall Street analysts LIGUA, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does LIGUA, Inc. pay dividends?

LIGUA, Inc. does not currently pay dividends.

What is LIGUA, Inc.’s EPS estimate?

LIGUA, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does LIGUA, Inc. have?

LIGUA, Inc. has 1,611,800 shares outstanding.

What happened to LIGUA, Inc.’s price movement after its last earnings report?

LIGUA, Inc. reported an EPS of -¥22.61 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.226%.

Which hedge fund is a major shareholder of LIGUA, Inc.?

Currently, no hedge funds are holding shares in JP:7090

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

LIGUA, Inc.

Ligua Inc., founded in Osaka, Japan in 2004, operates as a consulting firm primarily offering management support services within the healthcare sector. The company's activities are structured across two main divisions: Orthopedic Clinic Solutions and Financial Services. In its Orthopedic Clinic Solutions segment, Ligua develops and provides specialized software, such as Ligoo POS & CRM for managing patient information in osteopathic clinics, and ReceONE, a system designed for calculating receipts for health insurance claim submissions. This division also supplies a variety of medical devices and supplies, including EMS-indepth-, an electrical muscle stimulation unit; the Thomson bed, a hydraulic-electric treatment table used for addressing pelvic and spinal misalignments; Inject Energy, a low-frequency treatment device aimed at alleviating deep tissue pain and improving muscle atrophy; and Dr.Supporter, a general medical device utilizing Integrated Functional Mineral Crystal technology to enhance blood circulation, promote fatigue recovery, ease muscle soreness and stiffness, relieve neuralgia and lower back pain, and support core strength. Furthermore, it delivers educational training consulting, including tailored programs and online client attraction strategies for orthopedic clinics, alongside medical expense billing agency services. Ligua's Financial Services arm is involved in insurance agency activities, financial instrument intermediation, and offers financial advisory services, including mediation for mergers and acquisitions, to a diverse range of businesses.